Browsing Tag
Europe
95 posts
Infosys selected by ArcelorMittal as digital transformation partner
Infosys said that steel production company ArcelorMittal has selected the company to help expedite its digital transformation journey.…
April 9, 2021
Gan & Lee gets EMA orphan drug status for GLR2007 in glioma
Gan & Lee Pharmaceuticals has been granted orphan drug designation for GLR2007 from the European Medicine Agency (EMA)…
April 6, 2021
Bioniz Therapeutics gets EC orphan drug status for BNZ-1 for CTCL
Bioniz Therapeutics has secured orphan drug designation for BNZ-1 from the European Commission (EC) for the treatment of…
April 6, 2021
Önusberget wind farm : GE Renewable Energy bags contract for 137 turbines
GE Renewable Energy has signed an agreement with Luxcara, an asset management company, to deliver turbines for the…
March 6, 2021
Sedana Medical seeks approval for Sedaconda in Europe, eyes inhaled sedation for ICU patients
Sedana Medical, a prominent player in the field of medical sedatives, has officially submitted an application for regulatory…
November 29, 2020
Bristol Myers Squibb’s Opdivo receives EC approval for second-line treatment of ESCC
Bristol Myers Squibb (BMS) has achieved a significant milestone with the approval of its immunotherapy drug, Opdivo (nivolumab),…
November 24, 2020
Takeda to sell select non-core assets to Cheplapharm for $562m
Takeda Pharmaceutical has agreed to sell a portfolio of certain non-core prescription pharma products sold mainly in Europe…
September 9, 2020
Noxopharm launches NOXCOVID-1 clinical trial of Veyonda across Europe
Noxopharm, an Australian clinical-stage pharma company, has started the phase 1 NOXCOVID-1 clinical trial for Veyonda in Europe…
July 1, 2020
Sanofi, Regeneron secure Libtayo EMA approval for a type of skin cancer
Libtayo EMA approval : The European Commission has given conditional approval for Libtayo (cemiplimab) for the treatment of…
July 21, 2019
ViiV Healthcare secures Dovato EMA approval for HIV-1 treatment
Dovato EMA approval : The European Commission (EC) has approved ViiV Healthcare’s once-daily, single-pill, two-drug regimen Dovato (dolutegravir/lamivudine)…
July 14, 2019